IL3 CAR-T Cell Therapy for Patients With CD123 Positive Relapsed and/or Refractory Acute Myeloid Leukemia

NCT04599543 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
36
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Zhejiang University

Collaborators